早期耐受性和晚期持久性作为癌症治疗的替代药物反应
Simona Punzi1,2, Davide Cittaro3, Guido Gatti4,5
1Functional Genomics of Cancer Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy. punzi.simona@hsr.it.
Nature communications
|February 3, 2025
概括
人类癌细胞通过自和DNA修复激活产生药物诱导的耐受性. 这种由PINK1和HNF4A调节的反应可能会提高晚期癌症的化疗效果.
科学领域:
- 癌症生物学 癌症生物学
- 细胞机制 细胞机制
- 药物反应药物反应
背景情况:
- 细菌利用耐药性,持久性和耐受性来生存抗生素.
- 癌细胞中药物诱导的耐受性是鲜为人知的.
- 化疗疗效率通常受到细胞生存机制的限制.
研究的目的:
- 研究人类癌细胞中药物诱导耐受性的存在和机制.
- 为了确定这种耐受性反应的关键调节者.
- 探索药物诱导耐受性的治疗影响.
主要方法:
- 暴露人类癌细胞的化疗方案.
- 对自细胞激活和DNA损伤修复途径的分析.
- 研究PINK1和HNF4A在调节细胞反应中的作用.
主要成果:
- 化疗诱导癌细胞产生耐受性反应,其特点是自细胞激活和增强DNA修复.
- 长时间的药物暴露导致DNA修复的逆转,过渡到持久性.
- PINK1通过控制HNF4A局部化和转录活动来调节DNA修复减少.
结论:
- 标准治疗的抗瘤疗法可以在癌细胞中诱导药物诱导的耐受性反应.
- 这种耐受性涉及自和DNA损伤修复途径.
- 利用这种反应可以改善先进癌症的第一线,辅助和解压疗法的结果.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.5K
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
3.9K
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:20Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
01:21Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K